Actual Medicinal Product (AMP) Stribild 300mg/200mg/150mg/150mg tablets (Imported (United States))
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Data shows stability for up to 6 weeks in an open container.
- Provenance
-
This compatibility recommendation is derived from Stribild 150mg/150mg/200mg/245mg tablets (Gilead Sciences Ltd).
- Generic
- Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil
- Formulation
- Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets
-
Elvitegravir + Cobicistat + Emtricitabine + Tenofovir disoproxil
-
Elvitegravir 150mg / Cobicistat 150mg / Emtricitabine 200mg / Tenofovir disoproxil 245mg tablets
-
Stribild 300mg/200mg/150mg/150mg tablets (Imported (United States))
-
-